Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PFE | AZN |
|---|---|---|
| Price | $28.43 | $165.58 |
| Change today | ▲ 0.88% | ▲ 1.38% |
| Market cap | $162.03B | $256.80B |
| Return, 3 months | +20.3% | -8.9% |
| Return, year to date | +20.1% | -8.4% |
| Return, 1 year | +26.3% | +11.7% |
| P/E (TTM) | 37.4 | 24.8 |
| P/B | 1.9 | 5.1 |
| P/E percentile vs own 5y | 93rd | 13th |
| Dividend yield | 6.05% | 1.91% |
| Revenue growth (YoY, latest qtr) | +2.6% | +6.4% |
| Net profit growth (YoY) | -108.1% | +2.5% |
| Gross margin | 73.2% | 81.9% |
| Operating margin | 26.7% | 22.1% |
| Net margin | 6.8% | 17.0% |
| Return on equity | 5.0% | 22.0% |
| Analyst target vs. price | +1.3% | +32.0% |
| Analyst buy share | 35% | 88% |
| RSI (14) | 57 | 54 |
| 30-day volatility | 19.6% | 21.5% |
| Max drawdown, 1 year | -15.7% | -25.3% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.